Rolf Grempler

8PUBLICATIONS
36CO-AUTHORS
Epidemiological modellingMolecular medicineMolecular targetsCheminformatics and quantitative structure-activity relationshipsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 21, 2026
The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

|Dec 05, 2025
Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers.

Rolf Grempler, David Joseph, Guanfa Gan

|Oct 08, 2025
Relative Bioavailability of Zongertinib, an Orally Administered HER2-Selective Tyrosine Kinase Inhibitor, under Fed and Fasted Conditions in Healthy Male Participants: Results from Two Randomized, Open-Label, Crossover Studies.

Hélène Pereira, Stefan Wölke, Behbood Sadrolhefazi

|Dec 27, 2024
The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers.

Xiaofan Tian, Habib Esmaeili, David Minich

|Sep 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.

Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky

|Nov 16, 2023
Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis.

Rolf Grempler, Jennifer Ahlberg, Eva Germovsek

Pageof 2

Frequent Collaborators

3 joint publications

Fabian Müller

3 joint publications

Sven Wind

3 joint publications

Philipp M Roessner

2 joint publications

Guanfa Gan